- Albemarle’s net sales for the fourth quarter were $1.23 billion, a decrease of 48% from the previous year, and fell short of the estimated $1.29 billion.
- The company reported an adjusted EBITDA of $250.7 million, a significant improvement from a loss of $315.0 million in the previous year, exceeding the estimate of $180.4 million.
- Gross profit reached $138.2 million, recovering from a loss of $704.1 million the previous year, beating the expected $7.4 million.
- Energy storage net sales were $616.8 million, down 63% year-over-year, missing the forecasted $710.5 million.
- The energy storage segment recorded an adjusted EBITDA of $133.7 million, turning around from a loss of $338.3 million the previous year, outperforming the estimated $115.5 million.
- Specialties net sales were $332.9 million, just a 2% decline from the previous year, slightly below the estimated $342.4 million.
- In the specialties segment, adjusted EBITDA was $72.9 million, up from $29.8 million the previous year, surpassing the estimate of $64.1 million.
- Ketjen segment net sales totaled $281.9 million, a 17% decline from the previous year, below the expected $301.4 million.
- Ketjen’s adjusted EBITDA increased by 14% year-over-year to $35.8 million, although it did not meet the $41.5 million estimate.
- Albemarle is reducing its expected full-year 2025 capital expenditures by $100 million, now targeting expenditures between $700 and $800 million, a reduction of more than 50% from the prior year.
- Analyst recommendations include 13 buys, 17 holds, and 3 sells for Albemarle’s stock.
Albemarle Corp on Smartkarma
Analysts on Smartkarma, like Baptista Research, are closely watching Albemarle Corp, a company that recently showcased robust performance in its Q3 2024 earnings report. The report highlighted significant growth in the Energy Storage division and year-over-year EBITDA growth in its Specialties and Ketjen segments. Albemarle’s solid liquidity and leverage metrics, coupled with its strong operating cash conversion, have impressed experts. Baptista Research is delving into various factors that could impact Albemarle’s stock price in the near future and is conducting an independent valuation using a Discounted Cash Flow (DCF) methodology.
A look at Albemarle Corp Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Albemarle Corp, a company specializing in the production of specialty and fine chemicals, has been given a positive outlook based on the Smartkarma Smart Scores. With a strong value score of 4, Albemarle is deemed to be well-positioned in terms of its valuation relative to its industry peers. Additionally, the company scores moderately on dividend (3), reflecting its ability to provide returns to investors. However, the growth score of 2 suggests that there may be some challenges in terms of expansion opportunities.
Furthermore, Albemarle Corp has been rated a 3 for both resilience and momentum. This indicates that the company has shown some stability in weathering economic uncertainties and maintaining its performance, while also displaying a moderate level of momentum in its stock performance. Overall, Albemarle Corp‘s Smart Scores paint a mixed picture of its long-term prospects, with strengths in value and resilience balanced by lower scores in growth and momentum.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
